Literature DB >> 11553313

Loss of tuberin, the tuberous-sclerosis-complex-2 gene product is associated with angiogenesis.

P A Nguyen-Vu1, I Fackler, A Rust, J E DeClue, C A Sander, M Volkenandt, M Flaig, R S Yeung, R Wienecke.   

Abstract

BACKGROUND: Tuberous sclerosis complex (TSC) is an autosomal dominantly inherited disorder associated with an alteration of the TSC2 tumor suppressor gene which encodes for the protein product tuberin. The disease is characterized by the development of hamartomas, e.g. cutaneous angiofibromas which consist of vascular cells, interstitial cells, and normal components of the skin. The Eker rat model, an animal model of inherited cancer, has been shown to carry a mutation of TSC2.
METHODS: Immunohistochemical analyses of human angiofibromas were performed using antibodies directed against tuberin and angiogenic growth factors. Proliferation of human dermal microvascular endothelial cells (HDMEC) was determined after incubation with the supernatants of TSC2 (+/+) and TSC2 (-/-) rat embryonic fibroblasts (REF) that were derived from the Eker strain.
RESULTS: Loss of the expression of tuberin was observed in the interstitial cells of 13 of 39 angiofibromas. The expression of tuberin was retained in the vascular cells. In all analyzed angiofibromas, the angiogenic factors bFGF, PD-ECGF, VEGF and angiogenin were detected in the interstitial cells and/or vascular cells. Expression of PDGF-B and TGF-beta1 was weak. Tissue culture supernatants from TSC2 (-/-) REF stimulated the growth of HDMEC significantly more than supernatants from TSC2 (+/+) REF.
CONCLUSION: A functional loss of tuberin may stimulate vascular growth.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11553313     DOI: 10.1034/j.1600-0560.2001.028009470.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  14 in total

Review 1.  Nailing down a link between tuberin and renal cysts.

Authors:  David M Hockenbery
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

2.  Enhanced epidermal growth factor, hepatocyte growth factor, and vascular endothelial growth factor expression in tuberous sclerosis complex.

Authors:  Whitney E Parker; Ksenia A Orlova; Gregory G Heuer; Marianna Baybis; Eleonora Aronica; Michael Frost; Michael Wong; Peter B Crino
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

3.  Involvement of lymphatics in lymphangioleiomyomatosis.

Authors:  Connie G Glasgow; Angelo Taveira-DaSilva; Gustavo Pacheco-Rodriguez; Wendy K Steagall; Katsuya Tsukada; Xiong Cai; Souheil El-Chemaly; Joel Moss
Journal:  Lymphat Res Biol       Date:  2009-12       Impact factor: 2.589

Review 4.  Lymphangioleiomyomatosis and TSC2-/- cells.

Authors:  Thomas N Darling; Gustavo Pacheco-Rodriguez; Alfredo Gorio; Elena Lesma; Cheryl Walker; Joel Moss
Journal:  Lymphat Res Biol       Date:  2010-03       Impact factor: 2.589

5.  A vascular model of Tsc1 deficiency accelerates renal tumor formation with accompanying hemangiosarcomas.

Authors:  Jarrett D Leech; Stephen H T Lammers; Sam Goldman; Neil Auricchio; Roderick T Bronson; David J Kwiatkowski; Mustafa Sahin
Journal:  Mol Cancer Res       Date:  2014-12-29       Impact factor: 5.852

6.  Mesenchymal-epithelial interactions involving epiregulin in tuberous sclerosis complex hamartomas.

Authors:  Shaowei Li; Fumiko Takeuchi; Ji-An Wang; Qingyuan Fan; Toshi Komurasaki; Eric M Billings; Gustavo Pacheco-Rodriguez; Joel Moss; Thomas N Darling
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-21       Impact factor: 11.205

7.  TSC2 deficiency increases PTEN via HIF1alpha.

Authors:  Lenin Mahimainathan; Nandini Ghosh-Choudhury; Balachandar Venkatesan; Falguni Das; Chandi C Mandal; Nirmalya Dey; Samy L Habib; Balakuntalam S Kasinath; Hanna E Abboud; Goutam Ghosh Choudhury
Journal:  J Biol Chem       Date:  2009-07-31       Impact factor: 5.157

Review 8.  Lymphatic involvement in lymphangioleiomyomatosis.

Authors:  Connie G Glasgow; Angelo M Taveira-Dasilva; Thomas N Darling; Joel Moss
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

Review 9.  Lymphatics in lymphangioleiomyomatosis and idiopathic pulmonary fibrosis.

Authors:  Connie G Glasgow; Souheil El-Chemaly; Joel Moss
Journal:  Eur Respir Rev       Date:  2012-09-01

10.  Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex.

Authors:  James Brugarolas; Kui Lei; Rebecca L Hurley; Brendan D Manning; Jan H Reiling; Ernst Hafen; Lee A Witters; Leif W Ellisen; William G Kaelin
Journal:  Genes Dev       Date:  2004-11-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.